Ozempic® (Injection)
Brand-name Ozempic®, delivered
FDA-approved Ozempic® (semaglutide) — a once-weekly GLP-1 pen for weight management, reviewed online by licensed U.S. providers.
Overview
Ozempic® (semaglutide) is a brand-name, FDA-approved once-weekly GLP-1 injection from Novo Nordisk, prescribed to improve blood-sugar control in adults with type 2 diabetes and widely used to support appetite control and weight management.
How Ozempic® works
Mimics GLP-1
Stimulates glucose-dependent insulin release to help control blood sugar.
Curbs appetite
Reduces hunger and cravings to support weight management.
Slows digestion
Keeps you fuller for longer after meals.
At a glance — technical specifications
| Active ingredient | Semaglutide |
|---|---|
| Manufacturer | Novo Nordisk (brand-name) |
| Drug class | GLP-1 receptor agonist (incretin mimetic) |
| What it does | Improves blood-sugar control in type 2 diabetes; supports appetite control and weight management |
| How it works | Mimics GLP-1 — insulin release, slows digestion, reduces appetite |
| Form | Prefilled injection pen |
| Administration | Once weekly; self-injected |
| Dose range | 0.25 mg, 0.5 mg, 1.0 mg (gradual titration) |
| FDA status | FDA-approved (December 2017) for type 2 diabetes; also approved to reduce cardiovascular risk in adults with type 2 diabetes and known heart disease |
| Prescription | Required — issued after licensed provider review |
| Storage | Refrigerate 36–46°F (2–8°C); in-use pen per label |
Key benefits
The science
FDA-approved for type 2 diabetes. In the SUSTAIN trial program, Ozempic® lowered A1C and supported weight loss, and in SUSTAIN-6 reduced the risk of major cardiovascular events in people with established heart disease. Individual results vary.
FDA status
What's included with Mediclab
- Review by a licensed U.S. provider (all 50 states)
- Personalized treatment plan & titration
- Ongoing follow-up & refills
- Free shipping — HSA/FSA, insurance & Medicare may apply
Safety & side effects
Ozempic® is a registered trademark of Novo Nordisk A/S. Mediclab is not affiliated with, sponsored by, or endorsed by the trademark owner. Prescription required; dispensed only after provider review and approval. This information is for educational purposes only and is not medical advice. Individual results vary.
Free shipping
Easy return
Safe checkout